Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001477385 | SCV001681624 | likely benign | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2024-10-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003438821 | SCV004150981 | likely benign | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | RTEL1: BP4, BP7 |
Ambry Genetics | RCV004952932 | SCV005492515 | likely benign | Inborn genetic diseases | 2024-11-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001832623 | SCV002095423 | likely benign | Dyskeratosis congenita | 2021-10-15 | no assertion criteria provided | clinical testing |